News

April 17, 2019April 17, 2019

Starting Kalydeco Treatment Before Birth May Help Halt CF Progression Post-Birth, Animal Study Suggests

cystic fibrosis, News

Treating an animal model of cystic fibrosis (CF) with Kalydeco (ivacaftor) during embryonic development and after birth revealed that early treatment improved pancreatic function, delayed lung disease, and reduced infections, ... Read more

April 16, 2019April 16, 2019

Early Antibiotic Treatment Better to Eradicate New MRSA Infections in CF Patients, Study Suggests

cystic fibrosis, News

Using antibiotics to fully eliminate new methicillin-resistant Staphylococcus aureus (MRSA) airway infections appears more effective than waiting for the infection to pass naturally in patients with cystic fibrosis (CF), a ... Read more

April 15, 2019April 15, 2019

Incidence of Liver Disease and Cirrhosis Climbing in CF Patients, UK Registry Study Says

cystic fibrosis, News

A higher incidence of liver disease was found in people with cystic fibrosis (CF) in the U.K., according to a large cohort registry study. As liver disease is the third ... Read more

April 12, 2019April 12, 2019

Synspira’s CF Therapy Candidate SNSP113 Granted Orphan Drug Status in EU

cystic fibrosis, News

Synspira Therapeutics’s candidate for treating cystic fibrosis, SNSP113, has received orphan drug designation from the European Medicines’ Agency (EMA) in the European Union. The status was granted by the EMA’s Committee ... Read more

April 11, 2019April 11, 2019

Streptococcus, Haemophilus Bacteria Dominate Airways of CF Babies for First 2 Years, Study Says

cystic fibrosis, News

Bacteria species of the genus Streptococcus and Haemophilus are the most common in airways of children with cystic fibrosis (CF) for their first two years of life, a study reveals. The data ... Read more

April 9, 2019

Large Sugar Molecule Disrupts B. cepacia Bacteria from CF Patients, Study Shows

News

An experimental large sugar molecule called poly (acetyl, arginyl) glucosamine, or PAAG, was able to disrupt treatment-resistant biofilms formed by Burkholderia cepacia complex bacteria extracted from patients with cystic fibrosis ... Read more

April 8, 2019

Choline Supplementation Improves Lung Function, Liver Health in CF Patients, Study Shows

cystic fibrosis, News

Choline supplementation improves lung function and liver health in people with cystic fibrosis (CF), and should be considered as a complementary treatment to current standard care therapies, a study ... Read more

April 4, 2019April 4, 2019

Resura, First Prenatal Non-Invasive Test for Single-Gene Diseases Like CF, Launched by Progenity

cystic fibrosis, News

Resura Prenatal Test, the first non-invasive prenatal test for single-gene (monogenic) disorders such as cystic fibrosis (CF), has been launched by biotech company Progenity. The test screens fetal cell-free ... Read more

April 3, 2019April 3, 2019

Phase 2a Trial Will Test Molgradex in CF Patients with NTM Infections

cystic fibrosis, News

Savara Pharmaceuticals has launched a Phase 2a clinical study to evaluate the effectiveness of Molgradex in cystic fibrosis (CF) patients with chronic nontuberculous mycobacterial (NTM) lung infections. Molgradex is an ... Read more

April 2, 2019April 2, 2019

Virus that Infects Bacteria Turns Immune Response Away from P. aeruginosa, Study Shows

cystic fibrosis, News

Pseudomonas aeruginosa, the most common bacteria found in cystic fibrosis (CF) patients, uses a virus to go unnoticed by the host immune system, a new study shows. Treatment with ... Read more

Pin It on Pinterest